Home
/
Kraig Biocraft Laboratories, Inc.
/
Financials
/
Quarterly
Kraig Biocraft Laboratories, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Kraig Biocraft Laboratories, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$0
Nov 13, 2019
Q2
2019
Jun 30, 2019
$0
Aug 12, 2019
Q1
2019
Mar 31, 2019
$0
May 13, 2019
Q3
2019
Sep 30, 2018
$140.8K
Nov 13, 2019
Q2
2019
Jun 30, 2018
$152.2K
Aug 12, 2019
Q1
2019
Mar 31, 2018
$108.6K
May 13, 2019
Q3
2018
Sep 30, 2017
$27.2K
Nov 13, 2018
Q2
2018
Jun 30, 2017
$0
Aug 10, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2021
Jun 30, 2021
$0
Aug 12, 2021
Q2
2021
Jun 30, 2020
$0
Aug 12, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$108.6K
May 11, 2018
Q3
2017
Sep 30, 2017
$27.2K
Nov 15, 2017
Q2
2017
Jun 30, 2017
$0
Aug 14, 2017
Q1
2018
Mar 31, 2017
$0
May 11, 2018
Q3
2017
Sep 30, 2016
$18.7K
Nov 15, 2017
Q2
2017
Jun 30, 2016
$0
Aug 14, 2017
Q1
2017
Mar 31, 2016
$0
May 12, 2017
Q3
2016
Sep 30, 2015
$0
Nov 14, 2016
Q2
2016
Jun 30, 2015
$0
Aug 12, 2016
Q1
2016
Mar 31, 2015
$0
May 13, 2016
Q3
2015
Sep 30, 2014
$0
Nov 5, 2015
Q2
2015
Jun 30, 2014
$0
Aug 11, 2015
Q1
2015
Mar 31, 2014
$0
May 11, 2015
Q3
2014
Sep 30, 2013
$0
Oct 23, 2014
Q1
2013
Mar 31, 2013
$0
Dec 24, 2013
Q3
2013
Sep 30, 2012
$0
Nov 19, 2013
Q2
2012
Jun 30, 2012
$0
Sep 10, 2012
Q1
2013
Mar 31, 2012
$0
Dec 24, 2013
Q3
2012
Sep 30, 2011
$0
Nov 19, 2012
Q2
2012
Jun 30, 2011
$0
Sep 10, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.51M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($726.1K)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($1.51M)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($600.0K)
May 15, 2025
Q3
2025
Sep 30, 2024
($433.2K)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.61M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($507.9K)
May 15, 2025
Q3
2024
Sep 30, 2023
($549.3K)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($589.1K)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($566.8K)
May 14, 2024
Q3
2023
Sep 30, 2022
($810.4K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($1.04M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.05M)
May 12, 2023
Q3
2022
Sep 30, 2021
($3.19M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($2.75M)
Aug 1, 2022
Q1
2022
Mar 31, 2021
($940.7K)
May 6, 2022
Q3
2021
Sep 30, 2020
($693.2K)
Nov 5, 2021
Q2
2021
Jun 30, 2020
($568.8K)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($3.05M)
May 10, 2021
Q3
2020
Sep 30, 2019
($1.13M)
Nov 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.43M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($637.7K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($580.5K)
May 15, 2025
Q3
2025
Sep 30, 2024
($423.8K)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.49M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($448.7K)
May 15, 2025
Q3
2024
Sep 30, 2023
($459.4K)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($480.7K)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($486.6K)
May 14, 2024
Q3
2023
Sep 30, 2022
($525.3K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($536.7K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($545.7K)
May 12, 2023
Q3
2022
Sep 30, 2021
($872.5K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($705.2K)
Aug 1, 2022
Q1
2022
Mar 31, 2021
($665.0K)
May 6, 2022
Q3
2021
Sep 30, 2020
($598.5K)
Nov 5, 2021
Q2
2021
Jun 30, 2020
($470.3K)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($2.96M)
May 10, 2021
Q3
2020
Sep 30, 2019
($1.06M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($335.2K)
Jul 31, 2020